Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas

Joshua D. Schiffman, J. Graeme Hodgson, Scott R. Vandenberg, Patrick Flaherty, Mei Yin C. Polley, Mamie Yu, Paul G. Fisher, David H. Rowitch, James M. Ford, Mitchel S. Berger, Hanlee Ji, David H. Gutmann, C. David James

Research output: Contribution to journalArticlepeer-review

194 Scopus citations

Fingerprint Dive into the research topics of 'Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas'. Together they form a unique fingerprint.

Medicine & Life Sciences